Search by Drug Name or NDC

    NDC 00078-0109-01 Sandimmune 50 mg/mL Details

    Sandimmune 50 mg/mL

    Sandimmune is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is CYCLOSPORINE.

    Product Information

    NDC 00078-0109
    Product ID 0078-0109_5fd4ecdc-1dd9-4887-8817-d63e871d5c92
    Associated GPIs 99402020002005
    GCN Sequence Number 062197
    GCN Sequence Number Description cyclosporine AMPUL 250 MG/5ML INTRAVEN
    HIC3 Z2E
    HIC3 Description IMMUNOSUPPRESSIVES
    GCN 97981
    HICL Sequence Number 004524
    HICL Sequence Number Description CYCLOSPORINE
    Brand/Generic Brand
    Proprietary Name Sandimmune
    Proprietary Name Suffix n/a
    Non-Proprietary Name cyclosporine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 50
    Active Ingredient Units mg/mL
    Substance Name CYCLOSPORINE
    Labeler Name Novartis Pharmaceuticals Corporation
    Pharmaceutical Class Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA050573
    Listing Certified Through 2025-12-31

    Package

    NDC 00078-0109-01 (00078010901)

    NDC Package Code 0078-0109-01
    Billing NDC 00078010901
    Package 10 AMPULE in 1 BOX (0078-0109-01) / 5 mL in 1 AMPULE (0078-0109-61)
    Marketing Start Date 1983-11-14
    NDC Exclude Flag N
    Pricing Information N/A